T1	PROC 300 330	recambio a través de catéteres
T2	ANAT 82 91	plaquetas
#1	AnnotatorNotes T2	C0005821; Blood Platelets; Cell
T3	CHEM 110 120	TICagrelor
#2	AnnotatorNotes T3	C1999375; ticagrelor; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T4	PROC 135 182	implantación de la válvula aórtica transcatéter
T5	ANAT 154 169	válvula aórtica
#3	AnnotatorNotes T5	C0003501; Aortic valve structure; Body Part, Organ, or Organ Component | C1269005; Entire aortic valve; Body Part, Organ, or Organ Component
T6	PROC 187 201	estudio piloto
#4	AnnotatorNotes T6	C0031928; Pilot Projects; Research Activity
T7	ANAT 243 258	válvula aórtica
#5	AnnotatorNotes T7	C0003501; Aortic valve structure; Body Part, Organ, or Organ Component | C1269005; Entire aortic valve; Body Part, Organ, or Organ Component
T8	DISO 372 389	estenosis aórtica
#6	AnnotatorNotes T8	C0003507; Aortic Valve Stenosis; Disease or Syndrome
T9	ANAT 420 435	válvula aórtica
#7	AnnotatorNotes T9	C0003501; Aortic valve structure; Body Part, Organ, or Organ Component | C1269005; Entire aortic valve; Body Part, Organ, or Organ Component
T10	PROC 488 501	Diagnosticado
#8	AnnotatorNotes T10	C0011900; Diagnosis; Diagnostic Procedure
T11	DISO 506 523	estenosis aórtica
#9	AnnotatorNotes T11	C0003507; Aortic Valve Stenosis; Disease or Syndrome
T12	PROC 565 572	cirugía
#10	AnnotatorNotes T12	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T13	PROC 659 688	terapia antiplaquetaria doble
T14	ANAT 715 726	plaquetaria
#11	AnnotatorNotes T14	C0005821; Blood Platelets; Cell
T15	CHEM 796 807	Clopidogrel
#12	AnnotatorNotes T15	C0070166; clopidogrel; Organic Chemical · Pharmacologic Substance
T16	DISO 865 886	Fibrilación auricular
#13	AnnotatorNotes T16	C0004238; Atrial Fibrillation; Disease or Syndrome
T17	PROC 901 921	anticoagulación oral
#14	AnnotatorNotes T17	C0003281; Anticoagulation Therapy; Therapeutic or Preventive Procedure + C0001563; Administration, Oral; Therapeutic or Preventive Procedure | C1273553; Oral administration of treatment; Therapeutic or Preventive Procedure
T18	PROC 925 945	Anticoagulación oral
#15	AnnotatorNotes T18	C0003281; Anticoagulation Therapy; Therapeutic or Preventive Procedure + C0001563; Administration, Oral; Therapeutic or Preventive Procedure | C1273553; Oral administration of treatment; Therapeutic or Preventive Procedure
T19	PROC 1043 1047	TAVI
#16	AnnotatorNotes T19	C3509486; Transcatheter Aortic Valve Replacement; Therapeutic or Preventive Procedure
T20	DISO 960 983	hemorragia intracraneal
#17	AnnotatorNotes T20	C0151699; Intracranial Hemorrhage; Pathologic Function
T21	DISO 986 1021	Accidente cerebrovascular isquémico
#18	AnnotatorNotes T21	C0948008; Ischemic stroke; Disease or Syndrome
T22	DISO 1050 1058	Sangrado
#19	AnnotatorNotes T22	C0019080; Hemorrhage; Pathologic Function
T23	DISO 1090 1112	Insuficiencia hepática
#20	AnnotatorNotes T23	C0085605; Liver Failure; Disease or Syndrome | C1306571; Hepatic Insufficiency; Pathologic Function
T24	CHEM 1140 1183	inhibidores o inductores potentes de CYP34A
T25	CHEM 1193 1197	ISRS
#21	AnnotatorNotes T25	C0360105; Selective Serotonin Reuptake Inhibitors; Pharmacologic Substance
T26	CHEM 1199 1209	Paroxetina
#22	AnnotatorNotes T26	C0070122; paroxetine; Organic Chemical · Pharmacologic Substance
T27	CHEM 1211 1221	Sertralina
#23	AnnotatorNotes T27	C0074393; sertraline; Organic Chemical · Pharmacologic Substance
T28	CHEM 1223 1233	Citalopram
#24	AnnotatorNotes T28	C0008845; citalopram; Organic Chemical · Pharmacologic Substance
T29	ANAT 1282 1293	plaquetaria
#25	AnnotatorNotes T29	C0005821; Blood Platelets; Cell
T30	CHEM 1335 1343	aspirina
#26	AnnotatorNotes T30	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T31	CHEM 1345 1356	clopidogrel
#27	AnnotatorNotes T31	C0070166; clopidogrel; Organic Chemical · Pharmacologic Substance
T32	CHEM 1359 1369	ticagrelor
#28	AnnotatorNotes T32	C1999375; ticagrelor; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T33	ANAT 1384 1393	plaquetas
#29	AnnotatorNotes T33	C0005821; Blood Platelets; Cell
T34	ANAT 382 389	aórtica
#30	AnnotatorNotes T34	C0003501; Aortic valve structure; Body Part, Organ, or Organ Component | C1269005; Entire aortic valve; Body Part, Organ, or Organ Component
T35	PROC 408 448	implante de válvula aórtica transcatéter
T36	ANAT 516 523	aórtica
#31	AnnotatorNotes T36	C0003501; Aortic valve structure; Body Part, Organ, or Organ Component | C1269005; Entire aortic valve; Body Part, Organ, or Organ Component
T37	PROC 741 747	prueba
#32	AnnotatorNotes T37	C1510438; Assay; Laboratory Procedure
T38	PROC 780 791	tratamiento
#33	AnnotatorNotes T38	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T39	PROC 858 862	TAVI
#34	AnnotatorNotes T39	C3509486; Transcatheter Aortic Valve Replacement; Therapeutic or Preventive Procedure
T40	ANAT 877 886	auricular
#35	AnnotatorNotes T40	C0018792; Heart Atrium; Body Part, Organ, or Organ Component | C1280619; Entire atrium; Body Part, Organ, or Organ Component
T41	ANAT 971 983	intracraneal
#36	AnnotatorNotes T41	C0524466; Intracranial; Body Location or Region
T42	DISO 1061 1080	diátesis patológica
T43	ANAT 1104 1112	hepática
#37	AnnotatorNotes T43	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T44	PROC 1261 1293	doble antiagregación plaquetaria
T45	PROC 1372 1393	Recuento de plaquetas
#38	AnnotatorNotes T45	C0032181; Platelet Count measurement; Laboratory Procedure
T46	Date 13 17	2019
T47	LIVB 226 235	Pacientes
#39	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	DEVI 321 330	catéteres
#40	AnnotatorNotes T48	C0085590; catheter device; Medical Device
T49	LIVB 358 367	Pacientes
#41	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Age 476 485	> 18 años
T53	Date 606 614	actuales
T54	Neg_cue 655 658	Sin
T55	Route 917 921	oral
#42	AnnotatorNotes T55	C1527415; Oral Route of Drug administration; Functional Concept
T56	Route 941 945	oral
#43	AnnotatorNotes T56	C1527415; Oral Route of Drug administration; Functional Concept
T57	Duration 1022 1033	los 14 días
T59	Duration 1302 1309	3 meses
T60	PHYS 1404 1412	Embarazo
#44	AnnotatorNotes T60	C0032961; Pregnancy; Organism Function
T61	PHYS 1415 1424	lactancia
#45	AnnotatorNotes T61	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T52	PHYS 67 91	REACtividad de plaquetas
#46	AnnotatorNotes T52	C0032176; Platelet aggregation; Organ or Tissue Function
T58	PHYS 703 726	Reactividad plaquetaria
#47	AnnotatorNotes T58	C0032176; Platelet aggregation; Organ or Tissue Function
A2	Assertion T13 Negated
A3	Assertion T39 Contraindicated
A4	Status T20 History_of
A5	Assertion T44 Contraindicated
A6	Assertion T30 Contraindicated
A7	Assertion T31 Contraindicated
A8	Assertion T32 Contraindicated
A9	Status T13 History_of
#48	AnnotatorNotes T53	C0521116; Current (present time); Temporal Concept 
#49	AnnotatorNotes T4	C3509486; Transcatheter Aortic Valve Replacement; Therapeutic or Preventive Procedure
#50	AnnotatorNotes T35	C3509486; Transcatheter Aortic Valve Replacement; Therapeutic or Preventive Procedure
#51	AnnotatorNotes T13	C5197905; Dual Anti-Platelet Therapy; Therapeutic or Preventive Procedure
R2	Negation Arg1:T54 Arg2:T13	
R5	After Arg1:T52 Arg2:T4	
R6	Location_of Arg1:T5 Arg2:T4	
T63	DISO 243 279	válvula aórtica severamente estrecha
#53	AnnotatorNotes T63	C0003507; Aortic Valve Stenosis; Disease or Syndrome (?)
R7	Location_of Arg1:T7 Arg2:T63	
R8	Experiences Arg1:T47 Arg2:T63	
R9	Experiences Arg1:T47 Arg2:T1	
R10	Used_for Arg1:T48 Arg2:T1	
R11	Location_of Arg1:T34 Arg2:T8	
R12	Location_of Arg1:T36 Arg2:T11	
R13	Experiences Arg1:T49 Arg2:T8	
R14	Experiences Arg1:T49 Arg2:T35	
R15	Location_of Arg1:T9 Arg2:T35	
T64	Quantifier_or_Qualifier 524 530	severa
#54	AnnotatorNotes T64	C1547227; Severe - Severity of Illness Code; Intellectual Product
R16	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T64	
T65	Quantifier_or_Qualifier 390 395	grave
#55	AnnotatorNotes T65	C1547227; Severe - Severity of Illness Code; Intellectual Product
R17	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T65	
T66	Observation 533 544	Riesgo alto
#56	AnnotatorNotes T66	C4319571; High risk; Finding
R18	Before Arg1:T66 Arg2:T12	
T67	Observation 533 539;551 561	Riesgo intermedio
#57	AnnotatorNotes T67	C3640764; Intermediate Risk; Finding
R19	Before Arg1:T67 Arg2:T12	
R20	Overlap Arg1:T67 Arg2:T53	
R21	Overlap Arg1:T66 Arg2:T53	
R4	Before Arg1:T38 Arg2:T37	
R22	Used_for Arg1:T15 Arg2:T38	
R23	Location_of Arg1:T40 Arg2:T16	
R24	Has_Route_or_Mode Arg1:T17 Arg2:T55	
R25	Has_Route_or_Mode Arg1:T18 Arg2:T56	
R26	Location_of Arg1:T41 Arg2:T20	
R27	Overlap Arg1:T21 Arg2:T57	
R28	Before Arg1:T21 Arg2:T19	
#52	AnnotatorNotes T42	C1458140; Bleeding tendency; Pathologic Function (?)
R29	Location_of Arg1:T43 Arg2:T23	
T62	Quantifier_or_Qualifier 1081 1087	activa
#58	AnnotatorNotes T62	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R30	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T62	
T68	Quantifier_or_Qualifier 1113 1130	moderada a severa
#59	AnnotatorNotes T68	C1299393; Moderate to severe; Qualitative Concept
R31	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T68	
#60	AnnotatorNotes T44	C5197905; Dual Anti-Platelet Therapy; Therapeutic or Preventive Procedure
R32	Has_Duration_or_Interval Arg1:T44 Arg2:T59	
T69	Result_or_Value 1394 1401	<50,000
R33	Has_Result_or_Value Arg1:T45 Arg2:T69	
A1	Experiencer T47 Patient
A10	Experiencer T49 Patient
